R Wang, X Chen, H Li, X Chen, D Sun, D Yu… - International Journal of …, 2024 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious threat to human. Since there …
COVID-19 is threatening human health worldwide but no effective treatment currently exists for this disease. Current therapeutic strategies focus on the inhibition of viral replication or …
Y Yi, J Li, X Lai, M Zhang, Y Kuang, YO Bao… - Journal of advanced …, 2022 - Elsevier
Introduction The COVID-19 global epidemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a great public health emergency. Discovering antiviral drug …
TY Kim, S Jeon, M Ko, YE Du, SR Son… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Several plant-derived natural products with anti-SARS-CoV-2 activity have been evaluated for the potential to serve as chemotherapeutic agents for the treatment of COVID-19 …
NGM Attallah, AH El-Kadem, WA Negm, E Elekhnawy… - Pharmaceuticals, 2021 - mdpi.com
The global emergence of the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has focused the entire world's attention toward …
Flavonoids are important secondary plant metabolites that have been studied for a long time for their therapeutic potential in inflammatory diseases because of their cytokine-modulatory …
MF He, JH Liang, YN Shen, JW Zhang, Y Liu, KY Yang… - Life, 2022 - mdpi.com
Coronavirus Disease 2019 (COVID-19) is a highly infectious and pathogenic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early in this …
K Malekmohammad… - Current pharmaceutical …, 2021 - ingentaconnect.com
Background and Objective: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV- 2), a highly pathogenic virus, is responsible for a respiratory disease termed coronavirus …